Hybrid Canonical-Correlation Neural-Network Approach Applied to Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors (HEPT Derivatives)

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|17|1643-1659

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.17, 2003-09, pp. : 1643-1659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M.   Morrison I.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

Synthesis and Anti-HIV Evaluation of Novel 1,2,4-triazole Derivatives as Potential Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 1, 2013-01 ,pp. : 27-34

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of HEPT-Type HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Its Implications for DABO Family

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4165-4186

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR Study on Pyridinone Derivatives as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor: A Mixed Approach

By  

Medicinal Chemistry, Vol. 3, Iss. 3, 2007-05 ,pp. : 227-232

Bentham Science Publishers

Access to resources Recommend Favorite